To investigate what role SCF/KIT and NGF/TrkA signaling might play in NB and AML progression we studied how SCF and NGF protect cells against commonly used chemotherapeutic drugs (cytarabine-AraC and doxorubicin). This evidence concerns the gene NTRK1 and neuroblastoma.